FDA-led study highlights tradeoffs in drug promotion on social media

Providing both benefit and risk information within character-space-limited (CSL) drug promotions on social media platforms like Twitter improved recognition of risks but made it less likely that consumers would click links for additional information on the drug, according to a series of experimental studies led by the US Food and Drug Administration (FDA).